Systematic review of 9 studies (6 RCTs, 3 non-randomised) in type 2 diabetes with OSA: SGLT2 inhibitors reduced AHI vs other glucose-lowering drugs (MD -12.57) with similar adverse events; evidence quality was low to moderate.
Meta-analysisn = 9 studies
Yang et al. Sodium-glucose transporter 2 inhibitor for obstructive sleep apnea in patients with type 2 diabetes mellitus: A systematic review and meta-analysis